B Alert

Researchers explore the dangers of hepatitis B and HIV coinfection by Larry Buhl New research suggests people with chronic hepatitis B virus (HBV) infection have twice...

Care Costs

LifeGuide New HCV Meds Are on the Horizon, but Affordability May Still Remain a Challenge by Larry Buhl This column has covered several antiviral meds in...

Dos & Dont’s

Hep C Is Manageable—If You Know the Ins and Outs by Larry Buhl You’ve been diagnosed with Hepatitis C. Now what? First, don’t panic. Doctors agree...

Going Viral

While federal efforts move forward, hepatitis prevention remains unfunded by Larry Buhl During the seemingly interminable debate over health insurance reform, other health legislation was quietly...

Be Smart

In an Effort to Prevent HCV, One Campaign Is Educating Youth on Body Art Risks by Larry Buhl In the U.S., an estimated thirty-six percent of...

Clearing Hurdles

What can we do to address the obstacles to HCV treatment? by Larry Buhl Hepatitis C (HCV) is a “silent killer” in more ways than one....

REALIZE Gets Real

Hep Talk Hepatitis C Antiviral Telaprevir Moves Closer to Approval by Larry Buhl Researchers in a recent Phase III study are encouraged by the results of a...

LATEST POSTS

AIDS Foundation Chicago: Free Webinars Exploring Racism in HIV & Public...

A&U is pleased to share this press release with you. AIDS Foundation Chicago hosts free webinars exploring racism in HIV and public health industries WHAT: ...

Pushcart Prize Nominees 2020

Tommy-Lee Baïk: Advocate